PUNE, India, July 13, 2016 /PRNewswire/ --
According to a new market research report "Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hopsital Laboratories, Reference Laboratories) - Global Forecast to 2021", published by MarketsandMarkets, The global market is projected to reach USD 4,768.9 Million by 2021 from USD 3,252.6 Million in 2016, at a CAGR of 8.0%.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 300 market data Tables and 50 Figures spread through 249 Pages and in-depth TOC on "Blood Culture Tests Market"
http://www.marketsandmarkets.com/Market-Reports/blood-culture-test-market-159606753.html
Early buyers will receive 10% customization on this report.
Factors such as rapidly rising aging population, increase in product approvals and launches, high incidence of bloodstream infections, high prevelance of infectious diseases, and increase in demand for rapid diagnostic techniques are driving the growth of the Blood Culture Tests Market during the forecast period.
In this report, the Blood Culture Tests Market is segmented on the basis of method, product, technology, application, end user, and region. Based on end user, the Blood Culture Tests Market is segmented into hospital laboratories, reference laboratories, academic research laboratories, and other laboratories (pathology laboratories, bacteriological laboratories, physician office laboratories (POLs), and independent research laboratories). The reference laboratories segment is expected to grow at the highest CAGR during the forecast period.
The high growth of this segment is attributed to the increasing outsourcing of blood culture tests by hospitals to reference laboratories, as they can perform a large volume of tests and are equipped with advanced diagnostic techniques that provide blood culture tests with a quick turnaround time.
Geographically, the Blood Culture Tests Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the Blood Culture Tests Market. However, the Asian market is expected to grow at the highest CAGR. Growth in the Asian market can be attributed to the high incidence of sepsis and government initiatives to increase awareness on the disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region.
Talk To Our Research Experts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=159606753
The Blood Culture Tests Market is highly competitive, with prominent players such as Becton, Dickinson and Company (U.S.), bioMérieux SA (France), and Thermo Fisher Scientific, Inc. (U.S.). Some of the other players in this market include Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), IRIDICA (U.S.), Beckman Coulter (U.S.), Bruker Corporation (U.S.), and T2 Biosystems (U.S.).
Browse Related Reports:
Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021.
http://www.marketsandmarkets.com/Market-Reports/microbiology-testing-market-219135367.html
Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019.
http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html
Know More About our Knowledge Store @ http://www.marketsandmarkets.com/Knowledgestore.asp
About MarketsandMarkets:
MarketsandMarkets is the world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune - 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Email: [email protected]
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Share this article